IRIS
GIANNELLI, Gianluigi
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.018
EU - Europa 1.907
AS - Asia 1.177
SA - Sud America 25
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
AF - Africa 1
Totale 13.135
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.993
CN - Cina 705
SE - Svezia 619
SG - Singapore 383
IT - Italia 264
UA - Ucraina 249
DE - Germania 238
FI - Finlandia 170
GB - Regno Unito 158
FR - Francia 61
BE - Belgio 53
IE - Irlanda 32
IN - India 27
CA - Canada 20
VN - Vietnam 20
BR - Brasile 19
CZ - Repubblica Ceca 18
IR - Iran 14
NL - Olanda 13
JP - Giappone 11
RU - Federazione Russa 6
AU - Australia 4
ES - Italia 4
RO - Romania 4
HK - Hong Kong 3
HU - Ungheria 3
MX - Messico 3
AM - Armenia 2
AR - Argentina 2
AT - Austria 2
CH - Svizzera 2
CL - Cile 2
EU - Europa 2
LT - Lituania 2
NO - Norvegia 2
NP - Nepal 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BD - Bangladesh 1
CO - Colombia 1
CR - Costa Rica 1
DK - Danimarca 1
EC - Ecuador 1
EG - Egitto 1
HR - Croazia 1
ID - Indonesia 1
IL - Israele 1
JO - Giordania 1
LU - Lussemburgo 1
ME - Montenegro 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PL - Polonia 1
RS - Serbia 1
SA - Arabia Saudita 1
TR - Turchia 1
UZ - Uzbekistan 1
Totale 13.135
Salva come PNG Salva come JPEG
Città #
Fairfield 1.404
Chandler 1.135
Woodbridge 1.075
Ashburn 739
Houston 653
Jacksonville 565
Seattle 554
Wilmington 517
Nyköping 511
Cambridge 480
Ann Arbor 402
Singapore 254
Lawrence 208
Roxbury 202
Beijing 168
Nanjing 167
New York 125
Des Moines 110
Boardman 99
Inglewood 79
Princeton 77
San Diego 67
Brooklyn 54
Los Angeles 53
Brussels 51
Bari 49
Jiaxing 44
Santa Clara 41
London 40
Hebei 38
Shenyang 35
Tianjin 33
Dublin 32
Nanchang 32
Helsinki 29
Munich 27
Changsha 22
Paris 22
Washington 22
Redwood City 20
Dong Ket 19
Shanghai 18
Falls Church 17
San Mateo 17
Olomouc 15
Pune 15
Dearborn 14
Norwalk 13
Ardabil 12
Augusta 11
Guangzhou 11
Grumo Appula 10
Milan 10
Toronto 10
Edinburgh 9
Jinan 9
Kilburn 9
Leawood 9
San Francisco 9
Strasbourg 9
Hangzhou 8
Ostuni 8
Zhengzhou 8
Taranto 7
Tokyo 7
Ottawa 6
Rome 6
Amsterdam 5
Auburn Hills 5
Marseille 5
New Bedfont 5
Ningbo 5
Prescot 5
Romola 5
Stockholm 5
Taizhou 5
Wuhan 5
Chiswick 4
Grafing 4
Hanover 4
Islington 4
Monmouth Junction 4
Naples 4
Redmond 4
Romainville 4
Torrile 4
Triggiano 4
Yiwu 4
Brescia 3
Brno 3
Budapest 3
Frankfurt am Main 3
Genoa 3
Hounslow 3
Kunming 3
Mascalucia 3
Modena 3
Nakano 3
Phoenix 3
Sannicandro di Bari 3
Totale 10.661
Salva come PNG Salva come JPEG
Nome #
Innovative biomarkers in psychiatric disorders: a major clinical challenge in psychiatry 131
Social dysfunction in older age and relationships with cognition, depression, and apathy: The GreatAGE Study 131
Biopsychosocial frailty and the risk of incident dementia: The Italian longitudinal study on aging 129
NGS-based transcriptome profiling reveals biomarkers for companion diagnostics of the TGF-β receptor blocker galunisertib in HCC 128
Tumor-secreted lysophostatidic acid accelerates hepatocellular carcinoma progression by promoting differentiation of peritumoral fibroblasts in myofibroblasts 118
Lysophosphatidic acid receptor LPAR6 supports the tumorigenicity of hepatocellular carcinoma 114
Different Cognitive Frailty Models and Health- and Cognitive-related Outcomes in Older Age: From Epidemiology to Prevention 114
A pegylated interferon alpha-2b dose-reduction in HCV 1b patients with rapid virological response does not affect sustained virological response 107
TGF-β as Multifaceted Orchestrator in HCC Progression: Signaling, EMT, Immune Microenvironment, and Novel Therapeutic Perspectives 107
BACE inhibitors in clinical development for the treatment of Alzheimer’s disease 105
Microenvironment inflammatory infiltrate drives growth speed and outcome of hepatocellular carcinoma: A prospective clinical study 102
Frizzled-10 Extracellular Vesicles Plasma Concentration Is Associated with Tumoral Progression in Patients with Colorectal and Gastric Cancer 102
Clinical role of tissue and serum levels of SCCA antigen in hepatocellular carcinoma 101
Imaging modification of colon carcinoma cells exposed to lipid based nanovectors for drug delivery: a scanning electron microscopy investigation 99
Clinical role of MMP-2/TIMP-2 imbalance in hepatocellular carcinoma 97
.: Cancer invasion: watch your neighbourhood! 97
TGF-β and the tissue microenvironment: Relevance in fibrosis and cancer 96
Hepatocytes activate HSC via MMP-9. Role of IFN-a2b in modulating liver fibrosis in HCV patients 94
The TGF-β pathway: a pharmacological target in hepatocellular carcinoma? 94
Pharmacotherapy for the treatment of depression in patients with alzheimer’s disease: a treatment-resistant depressive disorder 93
Immune cells and microbiota response to iron starvation 92
Dietary ω-3 polyunsaturated fatty acids inhibit tumor growth in transgenic Apcmin/+ mice, correlating with CB1 receptor up-regulation 90
Expression of matrix metalloprotease-2-cleaved laminin-5 in breast remodeling stimulated by sex steroids 89
Novel Transforming Growth Factor Beta Receptor I Kinase Inhibitor Galunisertib (LY2157299) in Advanced Hepatocellular Carcinoma 89
Rationale for new drugs targeting the tissue microenvironment in patients with HCC 88
Malignant fibrous histiocytoma arising on chronic osteomyelitis 88
A mesenchymal-like phenotype and expression of CD44 predict lack of apoptotic response to sorafenib in liver tumor cells. 88
Signaling networks in cholangiocarcinoma: molecular pathogenesis, targeted therapies and drug resistance 88
FZD10 Carried by Exosomes Sustains Cancer Cell Proliferation 88
Rat hindlimb unloading by tail suspension reduces osteoblast differentiation, induces IL-6 secretion, and increases bone resorption in ex-vivo cultures 87
Automatic transwell assay by an EIS cell chip to monitor cell migration 87
Midlife Metabolic Profile and the Risk of Late-Life Cognitive Decline 87
null 86
AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease 85
Galunisertib modifies the liver fibrotic composition in the Abcb4Ko mouse model 85
Polymeric nano-micelles as novel cargo-carriers for LY2157299 liver cancer cells delivery 85
Interplay between cancer cells, macrophages and natural killer cells may actually decide the outcome of therapy with sorafenib 84
Hepatic stellate cells stimulate HCC cell migration via laminin-5 production 84
PI3K Functions in Cancer Progression, Anticancer Immunity and Immune Evasion by Tumors 84
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study 84
Aquaporin 9 contributes to the maturation process and inflammatory cytokine secretion of murine dendritic cells 84
Precision medicine for hepatocelluar carcinoma using molecular pattern diagnostics: Results from a preclinical pilot study 84
Aerobic physical activity and a low glycemic diet reduce the AA/EPA ratio in red blood cell membranes of patients with NAFLD 84
Hepatitis C virus infection in anti-HBe-positive HBsAg carriers with chronic liver disease 82
Case of multiple myeloma mimicking an infectious disease with fever, intrahepatic cholestasis, renal failure, and pulmonary insufficiency 82
Moving towards personalised therapy in patients with hepatocellular carcinoma: the role of the microenvironment 82
Antibodies to interferon (IFN) in hepatitis C patients relapsing while continuing recombinant IFN-alpha2 therapy 81
Irisin Serum Levels in Metabolic Syndrome Patients Treated with Three Different Diets: A Post-Hoc Analysis from a Randomized Controlled Clinical Trial 81
Transforming growth factor-β promotes morphomechanical effects involved in epithelial to mesenchymal transition in living hepatocellular carcinoma 81
Development and specificities of anti-interferon neutralizing antibodies in patients with chronic hepatitis C treated with pegylated interferon-a 80
Gelatinase levels in male and female breast cancer 79
Tyrosine kinase inhibitors: a potential approach to the treatment of hepatocellular carcinoma 79
TGF-Beta Inihibitor-loaded Polyelectrolyte Multilayers Capsules for Sustained Targeting of Hepatocarcinoma Cells 79
Valore prognostico della neopterina nel siero di soggetti con infezione da HIV 78
Single hepatocellular carcinoma ranging from 3 to 5 cm: radiofrequency ablation or resection? 78
2',5’-Oligoadenylate synthetase activity as a responsive marker during interferon therapy for chronic hepatitis C 77
The epithelial-mesenchymal transition: fact or fiction in cancer? 77
Pegylated interferon α plus ribavirin for the treatment of chronic hepatitis C: a multicentre independent study supported by the Italian Drug Agency 77
PD-L1 expression in colorectal cancer defines three subsets of tumor immune microenvironments 77
Differential Inhibition of the TGF-β Signaling Pathway in HCC Cells Using the Small Molecule Inhibitor LY2157299 and the D10 Monoclonal Antibody against TGF-β Receptor Type II. 76
MxA and PKR expression in chronic hepatitis C 76
Plasma cholesterol and lipoprotein levels in relation to tumor aggressiveness and survival in HCC patients 76
Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5 75
Basiliximab versus steroids in double therapy immunosuppression in liver transplantation: a prospective randomized clinical trial 75
Glaucoma in primary amyloidosis:a fortuitous or a causative association? 75
The rationale for targeting TGF-β in chronic liver diseases 75
ZD6474 inhibits proliferation and invasion of human hepatocellular carcinoma cells 75
null 75
SCCA-IC serum levels are predictive of clinical response in HCV chronic hepatitis to antiviral therapy: a multicentric prospective study. 73
Key enabling technologies for point-of-care diagnostics 72
A pilot study of daily subcutaneous interleukin-10 in patients with chronic hepatitis C infection 72
null 72
Immune complexed (IC) hepatitis C virus (HCV) in chronically and acutely HCV-infected patients 71
Promising therapies for the treatment of frontotemporal dementia clinical phenotypes: from symptomatic to disease-modifying drugs 71
Involvement of ADAMs in tumorigenesis and progression of hepatocellular carcinoma: Is it merely fortuitous or a real pathogenic link? 70
Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5 70
SCCA Antigen combined with alpha-fetoprotein as serologic markers of HCC 70
null 70
null 70
Coffee intake and liver steatosis: A population study in a mediterranean area 70
Dietary fiber and health outcomes: An umbrella review of systematic reviews and meta-analyses 69
Clinical outcomes of bosentan in pulmonary arterial hypertension do not correlate with levels of TIMPs 68
MxA and PKR expression in chronic hepatitis C 68
Effects of interferon-alfa treatment on neutrophil oxidative metabolism, lymphocyte proliferation and monocyte HLA class I antigen expression in patients with chronic hepatitis C 68
null 68
Role of the Transforming Growth Factor-β in regulating hepatocellular carcinoma oxidative metabolism 68
Association between adherence to the Mediterranean Diet and circulating Vitamin D levels 68
The effect of bosentan on matrix metalloproteinase-9 levels in patients with systemic sclerosis-induced pulmonary hypertension 67
Kinase activation profile associated with TGF-β-dependent migration of HCC cells: a preclinical study 66
Proteolytic balance in patients with multiple sclerosis during interferon treatment 66
Role of the tissue microenvironment as a therapeutic target in hepatocellular carcinoma. 66
Pan-mTOR inhibitor MLN0128 is effective against intrahepatic cholangiocarcinoma in mice 65
Late-onset depression is associated to age-related central auditory processing disorder in an older population in Southern Italy 65
Characterization of morphological and cytoskeletal changes in MCF10A breast epithelial cells plated on laminin-5: comparison with breast cancer cell line MCF7 64
Occurrence of hepatitis delta virus infection in hepatitis B virus-infected patients with different serum patterns of preS geneencoded proteins 64
New frontiers in biomarkers for hepatocellular carcinoma 64
Nutritional domains in frailty tools: Working towards an operational definition of nutritional frailty 64
Proteolytic imbalance is reversed after therapeutic surgery in breast cancer patients 63
Drug-loaded polyelectrolyte microcapsules for sustained targeting of cancer cells 63
Differential tissue fatty acids profiling between colorectal cancer patients with and without synchronous metastasis 63
Totale 8.265
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.704
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.704
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.224 0 0 0 0 369 199 334 325 414 225 247 111
2020/20212.175 156 150 135 215 270 114 183 179 156 290 168 159
2021/20221.474 78 163 31 81 70 113 66 102 107 85 241 337
2022/20232.793 365 303 192 280 353 345 26 318 451 26 89 45
2023/2024982 66 178 61 78 84 233 47 34 15 44 18 124
2024/2025797 91 81 327 180 118 0 0 0 0 0 0 0
Totale 13.570